Clinical Trial Update: Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal. [Phase 1]

View source ↗

Summary

Phase 1 study in healthy volunteers to assess the oral bioavailability of cabotegravir (GSK1265744) under fasted and fed conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infection, Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED